Skip to main navigation menu Skip to main content Skip to site footer

Original research

Vol. 3 No. 1 (2025): January/December - 2025

Validation of Thyroid-Specific Quality of Life questionnaire Thypro-39 in Brazilian Portuguese

DOI
https://doi.org/10.52600/2965-0968.bjcmr.2025.3.1.bjcmr8
Submitted
May 18, 2024
Published
2024-07-22

Abstract

The purpose of the study is to validate ThyPRO-39 questionnaire to Brazilian Portuguese. The validated Portugal Portuguese version of ThyPRO-39, provided by the questionnaire developer, was used to adapt it to Brazilian Portuguese and these changes were validated by a translator. A cross-sectional study was carried out on people with thyroid disease, who were invited to participate in the research through the study author's social media. The study occurred between August 2020 and October 2020 and included 516 participants. Results obtained in both questionnaires, SF-36 and ThyPRO-39br, showed moderate correlation in all similar scales, Cronbach's alpha was higher than 0.7 in 10 of the 12 scales, and the clinical validation showed that results obtained were compatible with the expected for the patient diagnosis. Regarding the convergent validation between the ThyPro-39br and SF-36 questionnaires, the strongest correlations were found between the final composite score of ThyPRO-39br and SF-36 functional capacity (-0.591, p<0.001), impact on daily life and physical aspects (-0.568, p<0.001), and anxiety and mental health (-0.541, p<0.001). The ThyPRO-39br version was satisfactorily validated through 3 different methods and is available for future thyroid diseases quality of life research in Brazil.

References

  1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid Off J Am Thyroid Assoc. 2016 Jan; 26 (1): 1–133.
  2. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid Off J Am Thyroid Assoc. 2012 Dec; 22 (12): 1200–35.
  3. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000 Feb 28; 160 (4): 526–34.
  4. Bianchi GP, Zaccheroni V, Solaroli E, Vescini F, Cerutti R, Zoli M, et al. Health-related quality of life in patients with thyroid disorders. Qual Life Res. 2004 Feb; 13 (1): 45–54.
  5. Watt T, Hegedüs L, Rasmussen ÅK, Groenvold M, Bonnema SJ, Bjorner JB, et al. Which Domains of Thyroid-Related Quality of Life Are Most Relevant? Patients and Clinicians Provide Complementary Perspectives. Thyroid. 2007 Jul; 17 (7): 647–54.
  6. Boronat M, González-Lleó A, Rodríguez-Pérez C, Feldt-Rasmussen U, López-Plasencia Y, Rasmussen ÅK, et al. Adaptation and cross-cultural validation of the Spanish version of the Thyroid-Related Quality-of-Life Patient-Reported Outcome ques-tionnaire. Endocrinol Diabetes Nutr Engl Ed. 2018 Nov; 65 (9): 500–7.
  7. Giusti M, Gay S, Conte L, Cecoli F, Mortara L, Vera L, et al. Evaluation of Quality of Life in Patients with Differentiated Thyroid Cancer by Means of the Thyroid-Specific Patient-Reported Outcome Questionnaire: A 5-Year Longitudinal Study. Eur Thyroid J. 2020; 9 (5): 247–55.
  8. Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life ques-tionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol. 1998 Jul; 82 (7): 773–9.
  9. McMillan CV, Bradley C, Woodcock A, Razvi S, Weaver JU. Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism. Thyroid Off J Am Thyroid Assoc. 2004 Nov; 14 (11): 916–25.
  10. Watt T, Bjorner JB, Groenvold M, Cramon P, Winther KH, Hegedüs L, et al. Development of a Short Version of the Thy-roid-Related Patient-Reported Outcome ThyPRO. Thyroid. 2015 Oct; 25 (10): 1069–79.
  11. Watt T, Hegedüs L, Bjorner JB, Groenvold M, Bonnema SJ, Rasmussen AK, et al. Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothyroidism? Eur Thyroid J. 2012 Oct; 1 (3): 186–92.
  12. Bukvic BR, Zivaljevic VR, Sipetic SB, Diklic AD, Tausanovic KM, Paunovic IR. Improvement of quality of life in patients with benign goiter after surgical treatment. Langenbecks Arch Surg. 2014 Aug; 399 (6): 755–64.
  13. Cramon P, Winther KH, Watt T, Bonnema SJ, Bjorner JB, Ekholm O, et al. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study. Thyroid. 2016 Aug; 26 (8): 1010–8.
  14. Mishra A, Sabaretnam M, Chand G, Agarwal G, Agarwal A, Verma AK, et al. Quality of Life (QoL) in Patients With Benign Thyroid Goiters (Pre- and Post-Thyroidectomy): A Prospective Study. World J Surg. 2013 Oct; 37 (10): 2322–9.
  15. Zivaljevic VR, Bukvic Bacotic BR, Sipetic SB, Stanisavljevic DM, Maksimovic JM, Diklic AD, et al. Quality of life improvement in patients with Hashimoto thyroiditis and other goiters after surgery: A prospective cohort study. Int J Surg. 2015 Sep; 21: 150–5.
  16. Massolt ET, van der Windt M, Korevaar TIM, Kam BLR, Burger JW, Franssen GJH, et al. Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer. Clin Endocrinol (Oxf). 2016 Nov; 85 (5): 781–8.
  17. Ferreira PL. [Development of the Portuguese version of MOS SF-36. Part II - Validation tests]. Acta Med Port. 2000 Jun; 13 (3): 119–27.
  18. Watt T, Barbesino G, Bjorner JB, Bonnema SJ, Bukvic B, Drummond R, et al. Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Qual Life Res. 2015 Mar; 24 (3): 769–80.
  19. Sawicka-Gutaj N, Watt T, Sowiński J, Gutaj P, Waligórska-Stachura J, Ruchała M. ThyPROpl - The Polish version of the thy-roid-specific quality of life questionnaire ThyPRO. Endokrynol Pol. 2015; 66 (4): 367–80.
  20. Zahan AE, Watt T, Pascanu I, Rasmussen AK, Hegedüs L, Bonnema SJ, et al. THE ROMANIAN VERSION OF THE THY-ROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSS-CULTURAL VALIDITY. Acta Endocrinol Buchar Rom 2005. 2018 Jun; 14 (2): 192–200.
  21. Bukvić B, Živaljević V, Šipetić S, Diklić A, Taušanović K, Paunović I. Validation and cross-cultural adaptation of the ques-tionnaire ThyPRO in thyroid patients in Serbia. Vojnosanit Pregl. 2015 Jul; 72 (7): 583–8.
  22. Johri G, Chand G, Mishra A, Mayilvaganan S, Agarwal G, Agarwal A, et al. Endoscopic versus Conventional Thyroid Surgery: A Comparison of Quality of Life, Cosmetic Outcomes and Overall Patient Satisfaction with Treatment. World J Surg. 2020 Dec; 44 (12): 4118–26.
  23. Oddo S, Felix E, Mussap M, Giusti M. Quality of Life in Patients Treated with Percutaneous Laser Ablation for Non-Functioning Benign Thyroid Nodules: A Prospective Single-Center Study. Korean J Radiol. 2018; 19 (1): 175–84.
  24. Winther KH, Watt T, Bjørner JB, Cramon P, Feldt-Rasmussen U, Gluud C, et al. The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials. 2014 Apr 9; 15: 115.
  25. Du Puy RS, Postmus I, Stott DJ, Blum MR, Poortvliet RKE, Den Elzen WPJ, et al. Study protocol: a randomized controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over. BMC Endocr Disord [Internet]. 2018 Sep 19 [cited 2020 Dec 6]; 18. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146605/
  26. Husson O, Haak HR, Mols F, Nieuwenhuijzen GA, Nieuwlaat WA, Reemst PH, et al. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol Stockh Swed. 2013 Feb; 52 (2): 447–54.
  27. Ahn J, Jeon MJ, Song E, Kim TY, Kim WB, Shong YK, et al. Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation. Endocrinol Metab. 2020 Mar; 35 (1): 115–21.
  28. Mintziori G, et al. ThyPROgr: the Greek edition of the ThyPRO questionnaires for patients with benign thyroid diseases. Hormones (Athens). 2018 Mar;17(1):107-112.
  29. Wong CKH, et al. Measurement properties of ThyPRO short-form (ThyPRO-39) for use in Chinese patients with benign thyroid diseases. Qual Life Res. 2018 Aug;27(8):2177-2187.